Imagine living with pain so severe that something as simple as using a tampon is excruciating. That's the reality for women with vestibulodynia (VBD), a chronic pelvic pain condition. Researchers at Duke University wanted to see if they could find a better way to help. They enrolled 209 women with different subtypes of VBD in a carefully designed trial to compare three approaches: a cream containing lidocaine and estradiol, a pill called nortriptyline, or both treatments together. The goal was to see which one best reduced pain and improved quality of life over more than four years of follow-up. The study also looked for biological markers in the body that might predict who would respond to which treatment. This is a crucial step toward more personalized care. However, the specific results of this trial—how much pain improved, which treatment worked best, and what side effects occurred—are not yet available. While the hope is that this work will lead to better pain management, we're still waiting for the data to see what it actually found.
Can a cream or pill help women with chronic pelvic pain?
Photo by Cht Gsml / Unsplash
What this means for you:
Study tested pain treatments for women with chronic pelvic pain; results pending. More on Vestibulodynia
Higher third trimester estradiol levels associated with maternal hypothyroxinemia and lower FT4 High Estradiol Levels Link to Low Thyroid Hormone in Late Pregnancy
Frontiers · Apr 30, 2026
Transdermal Estradiol Patches Show Noninferiority to LHRH Agonists in Prostate Cancer Metastasis-Free Survival Men with advanced prostate cancer may have fewer hot flashes with a new patch treatment.
· Apr 23, 2026
Network meta-analysis of sedation strategies in therapeutic gastrointestinal endoscopy shows ketamine-propofol reduces hypoxia and bradycardia versus propofol-opioid. Better Sedation Choices Could Reduce Side Effects During Stomach Tests
Frontiers · Apr 21, 2026
Systematic review finds no progestogen class effect in oral contraception, with varying safety profiles A Safer Pill? How a New Generation of Birth Control May Lower Your Risk
Frontiers · Apr 12, 2026